{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNuC4ZcKDA","lastupdate":"2022-07-19T00:00:00.000Z","update_date":"2022-07-19T00:00:00.000Z","lastModified":"Sep 28, 2024","active":1,"confidence_score":100,"confidence_score_reason":"video or image, markets","urlname":"better","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$lPpuEMvdk8YslL8GelRdeOixYKiWdumSwrgIuYiYfjwZxDwC25S9JV","name":"Better","oneliner":"Medical-grade Cannabis","registrar":"514304427","website":"https://www.better-global.com/en/home","careerspage":"","founded_month":8,"founded_year":2009,"formernames":["Cann Pharmaceutical"],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCP-YsiejFjZttM39E3-FqlA","facebook":"https://www.facebook.com/bettermedicine","linkedin":"https://www.linkedin.com/company/69318818","instagram":"https://www.instagram.com/better.tm"},"social":["https://www.facebook.com/bettermedicine","https://www.youtube.com/channel/UCP-YsiejFjZttM39E3-FqlA","https://www.instagram.com/better.tm","https://www.linkedin.com/company/69318818"],"flattenedsociallinks":"https://www.facebook.com/bettermedicine|https://www.youtube.com/channel/UCP-YsiejFjZttM39E3-FqlA|https://www.instagram.com/better.tm|https://www.linkedin.com/company/69318818","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":11,"patent":0,"raised":15000000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Better","Cann Pharmaceutical"],"about":"Better specializes in developing medical-grade cannabis for a variety of medical conditions. The companys strains are developed with diverse CBD and THC combinations and high terpene levels in order to increase the efficiency and potency of its products for medical use. The company offers a range of products designed to address the particular medical needs of its clients.\r\n\r\nBetters medical-grade cannabis is a standardized and stable natural medicine grown by experts with many years of experience. Its contaminant-free product is guaranteed to contain a consistent level of active pharmaceutical ingredients, including THC, CBD, and other cannabinoids.\r\n\r\nThe company has developed eight unique strains with more in development. Betters strain diversity enables it to cover a wide range of conditions, and the strains offer an extensive variety of cannabinoid and terpene combinations, resulting in a plethora of smells, flavors, colors, and medicinal effects.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97236355101, +97236355101","country":null,"address":{"israeli":[{"id":"46430cdb-b6a3-4492-9c2c-534aecc9463e","city":"Tel Aviv-Yafo","type":null,"address":"HaYarkon Street 288, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"d69fc1e4-48c3-42e6-89ff-c0a25729e164","date":"Feb 16, 2022","link":"https://www.globenewswire.com/news-release/2022/02/16/2385835/0/en/InterCure-Signs-Definitive-Agreement-to-Acquire-Multi-National-Medical-Cannabis-Producer-Better.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"InterCure Ltd.","layoffs":null,"summary":"InterCure Ltd. has announced its acquisition of Cann Pharmaceutical Ltd. (Better), a medical cannabis multi-national operator. The acquisition is expected to strengthen InterCures position as the largest cannabis company outside of North America and expand its global reach. Betters unique strains and high-quality products will complement InterCures portfolio. The acquisition is expected to be accretive and create immediate value. The purchase price is USD 35 million, paid with InterCure shares at a valuation of USD 10 per share. The acquisition is subject to customary closing conditions and approvals. The transaction is expected to close in Q3 2022. InterCure is a leading cannabis company, while Better is a pharmaceutical-grade medical cannabis company known for its cultivation, marketing, and research expertise. The acquisition is a significant milestone in the cannabis industry and will accelerate InterCures global expansion plans.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["InterCure","Better","acquisition","medical cannabis","global expansion"],"date_of_event":"2022-02-16","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$35 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ooijorA0STVpIAyJse7VA2AJTZxTaN0e9tWI5j5ECswb1ONRltea2Q","news_summary":"InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer \"Better\"","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"96b62fba-fdf8-423a-8871-fecc90711980","date":"Apr 5, 2021","link":"https://www.globenewswire.com/news-release/2021/04/05/2204396/0/en/Subversive-Acquisition-LP-Announces-InterCure-s-Letter-of-Intent-Relating-to-the-Acquisition-of-a-Multi-National-Medical-Cannabis-Producer-Better-Holdings.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"InterCure Ltd.","layoffs":null,"summary":"InterCure Ltd. has signed a Letter of Intent to acquire Better Holdings, a medical cannabis operator in Israel and Australia. The acquisition strengthens InterCures position as the largest cannabis company outside of North America and expands its global reach. The companies expect to sign detailed and binding agreements within 90 days. The total consideration for the acquisition is USD $35 million, payable with InterCure shares. InterCure will also invest up to USD $2.5 million in Better Australia. The transaction is expected to enhance InterCures portfolio, distribution network, and partnerships.","partners":["Cann Pharmaceutical Ltd."],"customers":null,"investors":null,"confidence":8,"key_topics":["InterCure","Cann Pharmaceutical","Better Holdings","medical cannabis","global expansion"],"date_of_event":"April 5, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$35 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7OHH3iwRMHFmyuOCGUgw0RxHWdg21lj4xR9rHmwWqLaWEzCY14TCVq","news_summary":"Subversive Acquisition LP Announces InterCure's Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2b25b6d1-7584-4d06-b57d-cb911e84d6a2","date":"Sep 5, 2020","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_1518460_0_Txtetaxjxdshwhus8sp&did=1001341510","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Investment, Management Changes","company":"בטר","layoffs":"Not mentioned","summary":"בטר, an Israeli medical cannabis company, has raised $15 million from Thai investor Narin Niaotianon, in exchange for 32% of the company. The funds will enable the company to resume plans that were previously halted due to lack of budget, such as conducting comprehensive clinical trials on its products for epilepsy and autism, and expanding its operations in Australia. The companys CEO, Yaakov (Kobi) Molcho, took over after the departure of the previous management. בטר is also developing a specific product for autism, which already has a strong lobby of Israeli parents who swear by the product.","partners":"Not mentioned","customers":"Not mentioned","investors":"נארין ניאוטיאנון","confidence":8,"key_topics":["Investment","Management Changes","Cannabis Industry","Clinical Trials","Product Development"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Investment","Management Changes"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jRPqZZRfvvZ6ko8dbrLBHQVccMpIsDPo8xroY6deUqmtiu3C41Pake","news_summary":"חברת הקנאביס שכמעט התפרקה ועוזרת היום לילדים עם אוטיזם","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3bb28b34-038c-460a-ac0d-ce8aa12118f0","date":"Jun 15, 2020","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3833390,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"investment","company":"Better Holdings","layoffs":null,"summary":"Better Holdings, an Israeli cannabis company, has requested approval from Israels Ministry of Health for Narin Niruttinanon to become a controlling stakeholder in exchange for a $15 million investment. Better Holdings recently submitted a request to approve Niruttinanon as a controlling stakeholder, and he is set to invest $15 million for a 32% stake in the company. The deal values Better Holdings at $46.8 million, and the remaining 36% of the companys shares will stay with existing stakeholders. Niruttinanon is a real estate investor and the owner of Reading Football Club. Better Holdings hopes that the investment will help the company overcome its difficulties and promote clinical research for regulatory approval and a potential IPO in the future.","partners":null,"customers":null,"investors":"Narin Niruttinanon","confidence":9,"key_topics":["Investment","Stakeholder","Merger","Legal battle","Cannabis industry"],"date_of_event":"2020-06-15","valuation_amount":"$46.8 million","impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"K9gzNtdbTmzbunCPODIxyggfZWmndgpUhPN2qMbDF2QL4Zfb7ZL5ev","news_summary":"Thai businessman Narin Niruttinanon is the mysterious investor in Israeli cannabis company Better","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8d0d06f1-9d2c-446a-88ce-291cd191caa3","date":"Oct 29, 2019","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3772609,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"cannabis, sale, Israeli operations","company":"Better Holdings","layoffs":null,"summary":"Better Holdings, a medical cannabis company in Israel, is offering to sell its Israeli operations for NIS 20 million. The companys main point of interest is its stock of quality cannabis strains. Better used to be the second largest medical cannabis company in Israel but has faced trouble due to the countrys recent cannabis reform and the need to reissue its permanent license under new regulations. Better also operates in Australia with a farm, medical cannabis export and import licenses, and a clinical trial for epilepsy treatment.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["medical cannabis","Israeli operations","sale","cannabis strains","regulations"],"date_of_event":"10:3329.10.19","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"B2E8L1kVQsbH6CfmLbhfXUIUpc9ZpFSK90KpTg0k4lhdpS62AjNYT0","news_summary":"Cannabis Company Better Holdings Wants to Sell Israeli Operations","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ec509b32-84f2-40c7-bad9-5096dc3254ed","date":"Sep 3, 2019","link":"https://www.globes.co.il/news/article.aspx?did=1001299395","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Theft, Investment Interest","company":"Better Cannabis","layoffs":"Not mentioned","summary":"Better Cannabis, one of the largest and most profitable cannabis companies in Israel, recently suffered a theft of 350 kilograms of cannabis, estimated to be worth around 1.5 million shekels. The company has downplayed the incident, stating that the loss is not dramatic in relation to the companys operations. The company was recently supposed to merge with Whitesmoke, but the merger was cancelled. There is interest from the tech and gaming world to invest in the company, including from tech entrepreneur Gigi Levy-Weiss.","partners":"Not mentioned","customers":"Not mentioned","investors":"Gigi Levy-Weiss","confidence":8,"key_topics":["Cannabis Theft","Investment Interest","Management Changes","Company Valuation","Market Shortage"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-negative","investment_amount":"Not mentioned","structured_issues":"Management Changes","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"Growth-negative","analysisId":"b5f3hJebGNjGGIQXTftYde9WOKw3K0K6F7hWUN8CgakJa8RO2R9yft","news_summary":"350 קילו של קנאביס נגנבו מחוות חברת בטר","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c9cac3f1-a45c-4a3f-8b8e-c40883d8e22b","date":"Sep 13, 2016","link":"https://merryjane.com/health/better-yohai-gild-golan-israel-medical-marijuana","source":"merryjane.com","visible":1,"analysis":{"tags":"medicinal marijuana","company":"Better","layoffs":null,"summary":"Better, a medical-grade cannabis company founded by Yohai Gild Golan, has been advancing medicinal marijuana research in Israel. The Israeli governments support for medicinal marijuana use has allowed Better to conduct medical research and develop specific medical strains that can treat different ailments. Better played a key role in establishing Israels federally-approved medical marijuana program and has helped build the entire cannabis program from scratch. After almost a decade of research, Better is now preparing to share its findings with lawmakers and doctors worldwide. The companys focus is on developing and providing treatment-specific cannabis strains to those in need.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["medicinal marijuana research","Israel","medical-grade cannabis","medical marijuana program","treatment-specific cannabis strains"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"mYAPELpseIP7LjG1Ym7gqDX2fQFRALQ6rNSXqdLTbtLWCUrcv7rR6U","news_summary":"Better Founder Yohai Gild Golan and Israel Are Advancing Medicinal Marijuana Research for All","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d74dad28-3dc0-4d7e-9da3-5fe51a2a9aa9","date":"Jun 30, 2016","link":"http://www.canberratimes.com.au/act-news/medical-cannabis-to-be-trialled-in-treatment-of-melanoma-at-the-university-of-canberra-20160629-gpv18b.html","source":"www.canberratimes.com.au","visible":1,"analysis":{"tags":"medical cannabis","company":"University of Canberra","layoffs":null,"summary":"The University of Canberra has signed a million-dollar deal with Cann Pharmaceutical Australia to develop a new treatment for skin cancer using medicinal-grade cannabis. The two-year research project, led by Professor Sudha Rao, aims to create an immunotherapy treatment to complement traditional chemotherapy. Clinical trials will begin in the ACT next year, and the first results could be known within nine months. The hope is to create a treatment that will assist and boost the immune system for melanoma and other cancer patients. The medicinal cannabis used in the trials is a specialist strain grown in Israel. This research may also have implications for the legality of medicinal cannabis in Australia.","partners":"Cann Pharmaceutical Australia","customers":null,"investors":"Cann Pharmaceutical Australia","confidence":8,"key_topics":["skin cancer","clinical trials","immunotherapy","medical cannabis","melanoma"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kabRR0SKev2tlOg0dicZTkpKOBTg0a57HMTpI5IHlmtuMRHmEVNTz3","news_summary":"Medical cannabis to be trialled in treatment of melanoma at the University of Canberra","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[],"tags":["biotechnology","breeding","cannabis","pharmaceuticals","medical-technologies","pain-relief","autism"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B","B2B2C"],"productstage":"Released","products":[],"geomarkets":["Australia","Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$15M","totalrounds":1,"fundingstage":"Mature","totalfunding":"$15M","publicinvestors":1,"lastpublicfunding":15000000,"totalpublicrounds":1,"totalpublicfunding":15000000},"team":[{"name":"Yohai Golan-Gild","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwNuf_8sLDA","bounced":false,"claimed":0,"founder":1,"urlname":"yohai-golan-gild","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA25HRggoM","position":"Founder","last_name":"Golan-Gild","claimtoken":"ad05885cc192102bed8969647d7209540720b74f5174fe08b897ca8aaaec580b","first_name":"Yohai","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yohai-golan-gild-67092284","unsubscribed":false,"is_activeuser":0,"additionalemail":"yohaig@gmail.com","claimedemaildate":"2022-07-19 12:43:17.000000","initials":"YG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Assaf Dovrat","email":"assafdovrat@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4MnZj_sIDA","bounced":false,"claimed":0,"founder":0,"urlname":"assaf-dovrat","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgiY-QowkM","position":"VP BD","last_name":"Dovrat","claimtoken":"87b9de2e49d862b5fe16931385c964d3f3d98e932e1cde59eded2dc20a43933f","first_name":"Assaf","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/assaf-dovrat-a6828419/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-07-19 12:43:19.000000","initials":"AD","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ami Cohen","email":"amiel8cohen@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwLuR-5AKDA","bounced":false,"claimed":1,"founder":0,"urlname":"ami-cohen-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDAu8GLlgkM","position":"Int'l BD & Head of Sales & Distribution","last_name":"Cohen","claimtoken":"c3724504d76a46c4ded4f6d9682d9c4efd7ba2493717cc816a6eed330ba8b448","first_name":"Ami","picturekey":"$dHBR2QjOJzMV9Y41pKZoAiL3PHgtjm7lnjap8UmTeLemquqRKJRCjY","claimeddate":"2017-05-10","linkedinurl":"https://www.linkedin.com/in/ami-cohen-922ab475","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2017-05-10 12:25:36.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$dHBR2QjOJzMV9Y41pKZoAiL3PHgtjm7lnjap8UmTeLemquqRKJRCjY","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2020-01-27T00:00:00.000Z","crunchbaseid":"cann-pharmaceutical-better","lastupdator":"Jenny Sotnik-Talisman","lastupdator_email":"genys30@yahoo.com","creator":"Fredrik Liljedahl","creator_email":"fredrik.liljedahl@sncentral.org","createdate":"2017-05-09T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC9zZyVCQw","date":"Dec 2019","amount":"$15M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3833390,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Narin Niruttinanon","type":"Investor","amount":0,"hidden":false,"country":"Thailand","fullurl":"/investor_page/narin-niruttinanon","logokey":null,"tagline":"","urlname":"/investor_page/narin-niruttinanon","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCDurzyCAw","fundingtype":"Angel","leadpartner":null,"investmentid":"400d7f51-bad5-4e12-939d-ddcec92d4785","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"8/2009","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Better","logourl":"https://storage.googleapis.com/clean-finder-353810/$lPpuEMvdk8YslL8GelRdeOixYKiWdumSwrgIuYiYfjwZxDwC25S9JV","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$lPpuEMvdk8YslL8GelRdeOixYKiWdumSwrgIuYiYfjwZxDwC25S9JV","seoabout":"Better specializes in developing medical-grade cannabis for a variety of medical conditions. The companys strains are developed with diverse CBD and THC co...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Medical Cannabis","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Medical Cannabis"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Herbals","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Herbals"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Medical Cannabis"],"coreTechnology":["Biologicals","Herbals"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC9zZyVCQw","date":"Dec 2019","amount":"$15M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3833390,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Narin Niruttinanon","type":"Investor","amount":0,"hidden":false,"country":"Thailand","fullurl":"/investor_page/narin-niruttinanon","logokey":null,"tagline":"","urlname":"/investor_page/narin-niruttinanon","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCDurzyCAw","fundingtype":"Angel","leadpartner":null,"investmentid":"400d7f51-bad5-4e12-939d-ddcec92d4785","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}